Bristol scientists receive £1m to study childhood cancer

5 December 2011

Cancer treatment for young patients has been given a boost as neuroscientists in Bristol have been awarded more than £1 million in a bid to further research developments.

According to latest reports, scientists at the University of Bristol will target their study at how the brain controls movement and consider whether this has any effect on childhood cancer causes, side effects and treatments.

Action Medical Research has awarded the grant to the university's School of Physiology and Pharmacology.

Dr Nadia Cerminara, a research fellow at the university, said: "This project is the first important step by seeing if it is possible to do this. If successful the next step will be to use the recording method in future operations to produce a 'brain map' for each patient."

She added that currently researchers have not found reasons why some children suffer side effects of certain treatments and that there is no known way to reduce these complications.

Cerebellar tumours, a cancer of the brain, are the most common childhood form of cancer in the UK.

Posted by Jeanette Throughton

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)